OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protein kinase Cι mediates immunosuppression in lung adenocarcinoma
Ning Yin, Yi Liu, Capella Weems, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 671
Open Access | Times Cited: 10

Showing 10 citing articles:

Molecular mechanisms and clinical implications of the gold drug auranofin
Shuying Shen, Jie Shen, Zhong Luo, et al.
Coordination Chemistry Reviews (2023) Vol. 493, pp. 215323-215323
Closed Access | Times Cited: 24

Modulating the Chemical Reactivity of Gold Complexes in Living Systems: From Concept to Biomedical Applications
Jia Jiang, Xiaolin Xiong, Taotao Zou
Accounts of Chemical Research (2023) Vol. 56, Iss. 9, pp. 1043-1056
Closed Access | Times Cited: 19

MK886 Ameliorates Alzheimer's Disease by Activating the PRKCI/AKT Signaling Pathway
Ni Zheng, Zhi Zhang, Huan Liu, et al.
European Journal of Pharmacology (2025), pp. 177359-177359
Closed Access

Innovative Sarcoma Therapy Using Multifaceted Nano-PROTAC-Induced EZH2 Degradation and Immunity Enhancement
Zhihao Chen, Yi‐Yin Tai, Chuangzhong Deng, et al.
Biomaterials (2025) Vol. 321, pp. 123344-123344
Closed Access

Cell polarity proteins promote macropinocytosis in response to metabolic stress
Guillem Lambies, Szu-Wei Lee, Karen Duong‐Polk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

Tumor intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer
Ravindra Pramod Deshpande, Kerui Wu, Shih-Ying Wu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3669-3682
Closed Access | Times Cited: 2

Breaking the Invisible Barriers: Unleashing the Full Potential of Immune Checkpoint Inhibitors in Oncogene-Driven Lung Adenocarcinoma
Hoi‐Hin Kwok, Jiashuang Yang, David Lam
Cancers (2023) Vol. 15, Iss. 10, pp. 2749-2749
Open Access | Times Cited: 4

Ligand supplementation restores the cancer therapy efficacy of an antirheumatic drug auranofin from serum inactivation
Yuan Wang, Bei Cao, Qianqian Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Identification of novel targets and mechanisms of wogonin on lung cancer, bladder cancer, and colon cancer
Lin Zhou, Yunran Hu, Changxing Gao, et al.
Journal of Future Foods (2023) Vol. 4, Iss. 3, pp. 267-279
Open Access | Times Cited: 3

Cell polarity proteins promote macropinocytosis in response to metabolic stress
Guillem Lambies, Szu-Wei Lee, Karen Duong‐Polk, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access

Page 1

Scroll to top